Innovation-HERO-scientist with microscope.png

Working to improve the quality of healthcare through our investment in new technologies and services, clinical evidence and efficient and resilient manufacturing and distribution.

Life Unlimited

Driving growth through innovation

"We have a rich history of delivering innovations that truly matter, shaping clinical practice and improving outcomes. We will continue to deliver both incremental and transformative innovation, including across our scalable enterprise-wide innovation platforms of M-TECH and Biologics, and maintain a strong cadence of product launches across all business units."

Vasant Padmanabhan

President Research & Development, ENT and Emerging Markets

New platforms in M-TECH & Biologics

At the heart of our RISE strategy are our two key innovation platforms that are expected to deliver new products which can be scaled across our business units.

The first we refer to as M-TECH, a term we have created to define our innovation across Musculoskeletal Technologies to Enhance Care and Healing. Within M-TECH we currently have our unique robotics-assisted CORI◊ Surgical System for Orthopaedics, our new Spatial Surgery system TESSA◊ in Sports Medicine, which is pending FDA De Novo, and our patient monitoring system LEAF◊ in Advanced Wound Management.

The second platform is Biologics, where we anticipate taking products like REGENTEN◊, CARTIHEAL◊ AGILI-C◊, SANTYL◊ and our skin substitutes into new areas and indications, whilst adding new technologies that have wide-ranging applications.

Innovation-LEAF applied to patient.jpg

Building leadership in M-TECH

The CORI Surgical System, with its associated procedural applications, is the key to unlock increased procedural growth across reconstruction, and we are excited by the possibilities of the third generation product, CORI XT, which received FDA 510(k) clearance in December 2025.

TESSA Spatial Surgery (FDA De Novo pending) is the first-of-a kind arthroscopic video-based navigation that utilises patient-specific, image-based planning powered by AI algorithms with seamless workflow integration, fast set-up and a short learning curve, which we expect to represent the next technological leap for arthroscopy.

M-TECH also incorporates sensors to enhance patient care, such as the LEAF◊ Patient Monitoring System, acquired in 2019, which is designed to monitor and prevent pressure injuries. The next generation LEAF Patient Monitoring System, currently in development, will be cloud-based to drive more efficient installation and updates.

Innovation-CORI demonstration.jpg

From evolution to revolution: new products powering our next phase of growth

Recent product launches have been balanced across incremental and transformative innovations.

2023-2025 major launches driving growth

Innovation-New products launched.svg

You may also be interested in...

Title

Text